Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Research has documented 129 to 152 percent increases in angiogenesis in treated tissues, a dramatic improvement in the healing environment
Still, oral options will likely impact the market positively in terms of accessibility (an option for needle-phobic patients) and affordability
Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling
This concern may be caused by genetics, hormonal changes, or certain medications
These observations highlight the challenges associated with AS-IVs oral administration and underscore the potential of formulation strategies in enhancing its therapeutic efficacy
J Endocrinol (2014) 221:R3140
US$ 26.56
US$ 29.60
US$ 21.45
US$ 24.84
US$ 25.79
US$ 28.45
US$ 26.44
US$ 28.25
